April 1, 1998Diabetes
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Authors
Discussion
Loading...
Member takes
Implication
Review highlights the regulatory mechanisms of PPAR-gamma in adipogenesis and insulin sensitivity, suggesting pathways for designing improved therapies for insulin resistance.
Key Points
- Examine the molecular evidence establishing PPAR-gamma as a master regulator of adipose cell differentiation and as the therapeutic target for thiazolidinedione insulin sensitizers.
- Narrative synthesis of transcriptional pathways governing adipose cell differentiation and nuclear hormone receptor biology.
- Evaluation of mechanistic models linking ligand-dependent cofactor recruitment at PPAR-gamma to systemic insulin sensitivity.
- PPAR-gamma operates as an essential transcriptional regulator of adipogenesis and the primary functional receptor mediating the pharmacological actions of thiazolidinediones.
- Ligand-dependent recruitment of transcriptional cofactors controls receptor activation, offering a molecular framework to explain diverse physiological outcomes.
- Mechanistic gaps remain regarding how single receptor activation coordinates distinct physiological actions across metabolic tissues.
Cite This Study
Bruce M. Spiegelman (1998) studied this question.